Evergene, a 100 % subidiary of e-service provider MIT, and Stagen, a Tokyo-based service provider for clinical tests, have started their genetic analysis business „DearGene“. The focus is on genetic risk prediction of various life-style related diseases, female health management, food allergy and cancer. SNP analysis is handled by Takara Bio
Evergene press release, April 10, 2015
Evergene and Stagen start jointly into genetic analysis business